# Modular reconstruction and multilevel regulation of Saccharomyces cerevisiae to drive the efficient synthesis of asiatic acid

**Authors:** Chen Sang, Wenqian Wei, Xinran Yin, Qihang Chen, Xinglong Wang, Weizhu Zeng, Jingwen Zhou

PMC · DOI: 10.1016/j.synbio.2026.01.030 · Synthetic and Systems Biotechnology · 2026-02-27

## TL;DR

Scientists engineered yeast to efficiently produce asiatic acid, a valuable compound used in food, medicine, and cosmetics.

## Contribution

A high-yielding yeast platform was developed using modular reconstruction and multilevel metabolic engineering.

## Key findings

- A Saccharomyces cerevisiae strain was engineered to produce 170.4 mg/L of asiatic acid in a 5 L bioreactor.
- Metabolic engineering improved precursor supply and reduced cytotoxicity in the engineered yeast.
- Mitochondrial and cofactor balancing enhanced metabolic flux and energy supply for efficient production.

## Abstract

Asiatic acid, a pentacyclic triterpenoid compound, is highly valued in the fields of functional foods, pharmaceuticals, and cosmetics. However, its microbial synthesis has been constrained by an insufficient supply of key precursors. Additional challenges include cytotoxicity caused by intracellular terpenoid accumulation and imbalanced carbon metabolism. In this study, a high-yielding Saccharomyces cerevisiae platform strain was designed through modular reconstruction and multilevel metabolic engineering to enable efficient asiatic acid production. The supply of the critical precursor, α-amyrin, was enhanced by metabolic engineering, while cytotoxicity was alleviated via Raman spectroscopy-guided lipid droplet engineering. The catalytic efficiency of key P450 enzymes involved in ursolic acid synthesis was optimized, and mitochondrial engineering combined with cofactor balancing was employed to rectify metabolic flux imbalance and energy supply. Using this engineered platform strain, key enzymatic genes were introduced to construct an asiatic acid-producing strain. A fed-batch fermentation process in a 5 L bioreactor achieved an asiatic acid titer of 170.4 mg/L. A valuable reference for the efficient biosynthesis of asiatic acid and other triterpenoids is offered by the engineered platform established in this study.

Image 1

## Linked entities

- **Chemicals:** asiatic acid (PubChem CID 119034), α-amyrin (PubChem CID 73170), ursolic acid (PubChem CID 64945)
- **Species:** Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Genes:** HEM2 (porphobilinogen synthase HEM2) [NCBI Gene 852842] {aka OLE4, SLU1}, HAP4 (transcription factor HAP4) [NCBI Gene 853751], CYC1 (cytochrome c isoform 1) [NCBI Gene 853507], DGA1 (diacylglycerol O-acyltransferase) [NCBI Gene 854419], YEH1 (sterol esterase) [NCBI Gene 850648], ROX1 (Rox1p) [NCBI Gene 856178] {aka REO1}, POS5 (NADH kinase) [NCBI Gene 855913], QCR2 (ubiquinol--cytochrome-c reductase subunit 2) [NCBI Gene 856321] {aka COR2, UCR2}, PGK1 (phosphoglycerate kinase) [NCBI Gene 850370], YEH2 (sterol esterase) [NCBI Gene 850707], COX11 (Cox11p) [NCBI Gene 855971] {aka LPI13, PSO7}, MAE1 (malate dehydrogenase (oxaloacetate-decarboxylating)) [NCBI Gene 853839], ALD6 (aldehyde dehydrogenase (NADP(+)) ALD6) [NCBI Gene 856044] {aka ALD1}, NDI1 (NADH-ubiquinone reductase (H(+)-translocating) NDI1) [NCBI Gene 854919], ERG1 (squalene monooxygenase) [NCBI Gene 853086], ADH2 (alcohol dehydrogenase ADH2) [NCBI Gene 855349] {aka ADR2}, QCR6 (ubiquinol--cytochrome-c reductase subunit 6) [NCBI Gene 850593] {aka COR3, UCR6}, ARE2 (sterol acyltransferase) [NCBI Gene 855753] {aka SAT1}, ARE1 (sterol acyltransferase) [NCBI Gene 850415] {aka SAT2}, CYC3 (holocytochrome c synthase CYC3) [NCBI Gene 851192], HEM3 (hydroxymethylbilane synthase) [NCBI Gene 851322] {aka OLE2}, ERG7 (lanosterol synthase ERG7) [NCBI Gene 856470], IDP2 (isocitrate dehydrogenase (NADP(+)) IDP2) [NCBI Gene 850871], IDI1 (isopentenyl-diphosphate delta-isomerase IDI1) [NCBI Gene 855986] {aka BOT2, LPH10}, RIP1 (ubiquinol--cytochrome-c reductase catalytic subunit RIP1) [NCBI Gene 856689], HMX1 (Hmx1p) [NCBI Gene 850902], CYT1 (ubiquinol--cytochrome-c reductase catalytic subunit CYT1) [NCBI Gene 854231] {aka CTC1, YOR29-16}, COR1 (ubiquinol--cytochrome-c reductase subunit COR1) [NCBI Gene 852235] {aka QCR1}
- **Diseases:** hypoxic (MESH:D002534), growth retardation (MESH:D006130), inflammatory (MESH:D007249), cytotoxicity (MESH:D064420)
- **Chemicals:** acetyl-CoA (MESH:D000105), terpene (MESH:D013729), squalene (MESH:D013185), Ursolic acid (MESH:C005466), water (MESH:D014867), ethanol (MESH:D000431), 2,3-oxidosqualene (MESH:C002821), NaOH (MESH:D012972), n-hexane (MESH:C026385), Asiatic acid (MESH:C017032), oxygen (MESH:D010100), methanol (MESH:D000432), acetonitrile (MESH:C032159), carbon (MESH:D002244), MVA (MESH:C051113), nitrogen (MESH:D009584), Lipid (MESH:D008055), sterol (MESH:D013261), beta-amyrin (MESH:C036380), pentacyclic triterpenoid (MESH:D053978), alpha-Amyrin (MESH:C000654244), glucose (MESH:D005947), ursane (MESH:C000606873), PCT (MESH:D011080), pyridine (MESH:C023666), FeSO4.7H2O. (-), ethyl acetate (MESH:C007650), helium (MESH:D006371), triterpenoid (MESH:D014315), quillaic acid (MESH:C005564), K2SO4 (MESH:C031512), amino acids (MESH:D000596), heme (MESH:D006418), NADPH (MESH:D009249)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Lotus japonicus (species) [taxon 34305], Medicago truncatula (barrel medic, species) [taxon 3880], Prunella vulgaris (common self-heal, species) [taxon 39358], Ilex asprella (species) [taxon 185493], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702], Helianthus tuberosus (Jerusalem artichoke, species) [taxon 4233], Centella asiatica (Asiatic pennywort, species) [taxon 48106], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]
- **Mutations:** K15 N, L343A, lysine-asparagine, V249H
- **Cell lines:** UA13 — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_ZE99), Escherichia coli — Mus musculus (Mouse), Hybridoma (CVCL_C5CN), JM109 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963918/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963918/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963918/full.md

---
Source: https://tomesphere.com/paper/PMC12963918